- Advertisement -

UCB to Acquire Ra Pharma for $2.1B, Raising Rare Disease Presence

UCB CEO Jean-Christophe Tellier UCB plans to acquire Ra Pharmaceuticals for approximately $2.1 billion, the companies said today, in a deal designed to expand the...

$500M Merger Boosts NeuroRx VIP Guided Missile vs. COVID-19

NeuroRx says combination with Big Rock will help develop lead drugs against SARS-CoV-2 and bipolar depression . . . The post $500M Merger Boosts NeuroRx...

Achieving High Resolution LC Separations of Long-mer (>60mer) Oligonucleotides

Broadcast Date: May 25, 2023Time: 8:00 am PT, 11:00 am ET, 17:00 CET REGISTER NOW As nucleic acid therapeutics continue to expand and diversify, there...

Smart Bio Awards recognises innovators making an impact in Biotechnology –...

With Artificial Intelligence (AI) becoming increasingly ubiquitous in lifesciences, it should come as no surprise that it plays a crucial part in the field...

Study Finds Parkinson’s Disease May Be Predestined before Birth, and Identifies...

A study by researchers at Cedars-Sinai research has found that people who develop Parkinson’s disease before the age of 50 may have been born...

Cell and gene therapy CDMO Andelyn Biosciences celebrates over 20 years...

Andelyn Biosciences, a pioneer in the development and manufacturing of cell and gene therapies, today formally inaugurates its new manufacturing headquarters, the Andelyn Corporate...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key tumor defense against...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...

more new items

AI Drug Developer Xaira Therapeutics Launches with $1B+

Marc Tessier-Lavigne, PhD, Xaira Therapeutics founding CEO, and Bing presidential professor, head of laboratory at Stanford University AI-based drug developer Xaira Therapeutics has been launched...

Ludwig Lausanne scientists identify and show how to target a key...

April 24, 2024, NEW YORK – A Ludwig Cancer Research study has discovered how a lipid molecule found at high levels within tumors undermines...

Accelerating Research with Configurable Workflow, AI Assistants and FAIR Data

REGISTER NOW Broadcast Date:  Wednesday, April 24, 2024Time:  8:00 am PDT, 11:00 am EDT, 17:00 CEST Workflow design and data management are pivotal components...